Latest news
MoonLake Announces Positive Topline Results from the Phase 3 IZAR-1 Trial of Sonelokimab in Psoriatic Arthritis Demonstrating Significant Improvements Across all Clinical Endpoints, and Reports Second Quarter 2026 Financial Results - The Manila TimesThe Manila Times · Mon, 10 Aug 2026 11:19:23 GMTTECX: TX45 Phase 2 trial enrollment completed; topline results expected Q1 2027 - TradingViewTradingView · Thu, 06 Aug 2026 20:27:41 GMTQ32 Bio Reports Second Quarter 2026 Financial Results and Provides Corporate Update - TradingViewTradingView · Wed, 05 Aug 2026 10:59:00 GMTTenax Therapeutics reports Q2 net loss $17.8M, cash $118.0M; LEVEL Phase 3 topline due Aug 2026 - TradingViewTradingView · Fri, 31 Jul 2026 11:33:00 GMT